CompaniesInvestorsPeople
Home
Loading

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

Get in Touch

  • Contact

  • Request a Demo

  • Request Data Updates

  • Add a Company

Research

  • Companies

  • Investors

  • People

aVenture

  • Download App

  • Pricing

Download the aVenture Research beta for iOS and iPadOSDownload aVenture Research on the Mac App Store

Resources

  • Documentation

  • Use Cases

  • CLI

  • MCP

  • Feature Requests

  • Sitemap

Member

Backed by

Ask AI about aVenture

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy · Terms of Service

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading
Home›
Companies›
THOR Photomedicine›
Library
THOR Photomedicine

THOR Photomedicine

THOR Photomedicine manufactures photobiomodulation laser systems that let clinicians treat pain, dental and cancer-therapy side effects.

Operating headquarters
Amersham, Buckinghamshire, GB🇬🇧
Founded
1993
Loading
Overview
Compare
Employees
News
Library

THOR Photomedicine - Library

thorlaser.com·Crawled Oct 9, 2026·

Topics

Publication type

Content origin
Row density

Product

6 pages
  1. Low Level Laser / Photobiomodulation Therapy comes to dentistry - THOR Laser/dental
  2. Photobiomodulation (PBM Therapy) 8-hour Training Course - THOR Laser/courses
  3. Photobiomodulation (PBM Therapy) for neck pain video - THOR Laser/laser-neck-pain
  4. Photobiomodulation for Wound Healing - THOR Laser/wound

Press

1 page
  1. Add.htm/news/add.htm

About

1 page
  1. THOR Laser/about_thor/index.php

Contact

6 pages
  1. Contact Treatment.htm/contact-treatment.htm
  2. Contact.htm/contact.htm
  3. Customer Service.htm/customer-service.htm
  4. Low Level Laser Therapy Products - THOR Laser/purchase-enquiry.php

Homepage

2 pages
  1. Homepage/

    Photobiomodulation, Laser Therapy (LLLT) for tissue healing, inflammation, pain relief and wounds. Equipment and training for medical professionals only.

  2. Homepage/

    Photobiomodulation, Laser Therapy (LLLT) for tissue healing, inflammation, pain relief and wounds. Equipment and training for medical professionals only.

Privacy

1 page
  1. Privacy2.htm/privacy2.htm

Terms & Conditions

1 page
  1. Contract Manufacturing Opportunities - THOR Laser/contract

Coverage

8 items
  1. Children's Health Ireland: Photobiomodulation for the treatment of cancer therapy side effectsblog.thorlaser.com/childrens-health-ireland-photobiomodulation-for-the-treatment-of-cancer-therapy-side-effects/

    THOR Photomedicine highlighting Children's Health Ireland using photobiomodulation for its oncology and HSCT patients.

    Sep 2024 · blog.thorlaser.comBlog post

  2. THOR New Treat – The International Head & Neck Cancer Conferenceblog.thorlaser.com/thor-new-treat-the-international-head-neck-cancer-conference/

    A short film on the THOR LX2 desktop photobiomodulation unit, which treats pain, swelling and inflammation.

    Aug 2021 · blog.thorlaser.comBlog post

  3. American Oncology Network to be First Medical Oncology Network in United States to Offer THOR® Light Therapy at The Center for Cancer and Blood Disordersglobenewswire.com/news-release/2021/03/08/2188543/0/en/American-Oncology-Network-to-be-First-Medical-Oncology-Network-in-United-States-to-Offer-THOR-Light-Therapy-at-The-Center-for-Cancer-and-Blood-Disorders.html

    American Oncology Network plans to become the first medical oncology network in the United States to offer THOR® Light Therapy at The Center for Cancer and Blood Disorders. The technology is described as helping prevent oral mucositis in head and neck cancer patients undergoing radiation or chemoradiation.

    Mar 2021 · GlobeNewswireNews article

  4. Nursing students hope to treat opioid addiction with light therapyblog.thorlaser.com/nursing-students-hope-to-treat-opioid-addiction-with-light-therapy/

    WDVM report on Shepherd University nursing students using light therapy in a HRSA-funded study on West Virginia's opioid crisis.

    Feb 2020 · blog.thorlaser.comBlog post